Koesten Hirschmann & Crabtree
LLY icon

Koesten Hirschmann & Crabtree’s Eli Lilly LLY Stock Holding History

Koesten Hirschmann & Crabtree’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$913K Buy
789
+355
+82% +$419K 0.38% 18
2026
Q2 		$521K Buy
+434
New +$443K 0.22% 21
2025
Q2 		– Sell
-40
Closed -$33K – 349
2025
Q1 		$33K Hold
40
– – 0.02% 101
2024
Q4 		$30.9K Buy
+40
New +$33.1K 0.02% 102

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Koesten Hirschmann & Crabtree's LLY Position: Q3 2026 in Review

Koesten Hirschmann & Crabtree increased its Eli Lilly (LLY) stake by 82% in Q3 2026, buying an estimated $419K and bringing the position to 789 shares worth $913K. The position accounts for 0.38% of the portfolio, ranked #18.

Koesten Hirschmann & Crabtree first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Koesten Hirschmann & Crabtree held 789 shares of Eli Lilly worth $913K as of Q3 2026.
  • Koesten Hirschmann & Crabtree bought 355 Eli Lilly shares in Q3 2026, an estimated $419K.
  • Eli Lilly made up 0.38% of Koesten Hirschmann & Crabtree's portfolio in Q3 2026, its #18 holding.
  • Koesten Hirschmann & Crabtree first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q3 2026, filed 13 Oct 2026.